"Das Klinikum Links der Weser ist eines von vier Häusern des Bremer Klinikverbundes Gesundheit Nord. Bei uns werden pro Jahr etwa 27.000 Patientinnen und Patienten stationär und teilstationär behandelt. Rund 1330 Mitarbeiterinnen und Mitarbeiter sorgen dafür, dass es ihnen bald wieder besser geht und sie so gut wie möglich umsorgt werden. Seit vielen Jahren ist das Klinikum Links der Weser auf die Behandlung von Patienten mit Herzerkrankungen spezialisiert – vom Frühchen mit angeborenem Herzfehler bis zum älteren Herzschrittmacherpatienten. Im Infarktzentrum des Klinikums werden Menschen aus Bremen und der Region versorgt, die einen Herzinfarkt erleiden – hochprofessionell, schnell und 24 Stunden am Tag."

During the past decade, Klinikum Links der Weser conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Links der Weser" #1 sponsor was "IHF GmbH - Institut für Herzinfarktforschung" with 2 trials, followed by "Stiftung Institut fuer Herzinfarktforschung" with 2 trials sponsored, "The Medicines Company" with 2 trials sponsored, "University of Leipzig" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Links der Weser" #1 collaborator was "Abbott Medical Devices" with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Competence Network for Congenital Heart Defects" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Links der Weser" are "Myocardial Infarction" (3 trials), "Acute Coronary Syndrome" (2 trials), "Antithrombotic Therapy" (1 trials), "Aortic Dissection" (1 trials) and "Aortic Valve Disease" (1 trials). Many other conditions were trialed in "Klinikum Links der Weser" in a lesser frequency.

Most popular intervention types in "Klinikum Links der Weser" are "Drug" (6 trials), "Device" (5 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bivalirudin" (2 trials), "ABSORB Scaffold" (1 trials), "Apixaban" (1 trials), "CAVGJ" (1 trials) and "Cardiac resynchronisation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Links der Weser" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Links der Weser". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Klinikum Links der Weser, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Links der Weser, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".